Australian Drinking Water Map

Logan East (Queensland) – Lead

2016/2017: Logan East Lead 0.019mg/L (max)

Lead Guideline reduced from 0.01mg/L to 0.005mg/L in June 2025. “The concentration of lead in water within premises may be higher, especially in older buildings, due to contact of the water with lead-containing plumbing products (enHealth 2021). A review found several Australian and international studies that detected up to 0.162 mg/L of lead in drinking water due to leaching from lead-containing plumbing materials including taps and lead service lines, suggesting that leaching of lead from lead-containing plumbing materials can be substantial (SLR 2023)… Based on health considerations, the concentration of lead in drinking water should not exceed 0.005 mg/L.”

Logan East Water Supply Zone (Queensland) – Bromodichloromethane

2019/20:  Logan East Water Supply Zone Bromodichloromethane (Trihalomethane) 59ug/L. (2019/20 av. 31ug/L)

WHO Guideline level BDCM: 60ug/L (Australian Guideline for BDCM is included in the Trihalomethane (THM) combined total of BDCM, Chloroform, Dibromochloromethane and Bromoform. THM guideline is 250ug/L)

“Carcinogenicity : Bromodichloromethane is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
Cancer Studies in Experimental Animals: Oral exposure to bromodichloromethane caused tumors at several different tissue sites in mice and rats. Administration of bromodichloromethane by stomach tube caused benign and malignant kidney tumors (tubular-cell adenoma and adenocarcinoma) in male mice and in rats of both sexes, benign and
malignant liver tumors (hepatocellular adenoma and carcinoma) in female mice, and benign and malignant colon tumors (adenomatous polyps and adenocarcinoma) in rats of both sexes (NTP 1987, ATSDR 1989, IARC 1991, 1999).

Since bromodichloromethane was listed in the Sixth Annual Report on Carcinogens, additional studies in rats have been identified. Administration of bromodichloromethane in the drinking water increased the combined incidence of benign and malignant liver tumors (hepatocellular adenoma or carcinoma) in males (George et al. 2002) and caused benign liver tumors (hepatocellular adenoma) in females (Tumasonis et al. 1987).

Cancer Studies in Humans
The data available from epidemiological studies are inadequate to evaluate the relationship between human cancer and exposure specifically to bromodichloromethane. Several epidemiological studies indicated a possible association between ingestion of chlorinated drinking water (which typically contains bromodichloromethane) and increased risk of
cancer in humans, but these studies could not provide information on whether any observed effects were due to bromodichloromethane or to one or more of the hundreds of other disinfection by-products also present in chlorinated water (ATSDR 1989).” (1)

2016/20: Logan East Water Supply Zone (Queensland). Bromodichloromethane, Lead

in , ,
Logan East (Queensland) – Lead 2016/2017: Logan East Lead 0.019mg/L (max) Lead Guideline reduced from 0.01mg/L to 0.005mg/L in June 2025. “The concentration of lead in water within premises may be higher, especially in older buildings, due to contact of the water with lead-containing plumbing products (enHealth 2021). A review found several Australian and international studies that detected up to 0.162 mg/L of lead in drinking water due to leaching from lead-containing plumbing materials including taps and lead service lines, suggesting that leaching of lead from lead-containing plumbing materials can be substantial (SLR 2023)… Based on health considerations, the concentration of lead in drinking water should not exceed 0.005 mg/L.” Logan East Water Supply Zone (Queensland) – Bromodichloromethane 2019/20:  Logan East Water Supply Zone Bromodichloromethane (Trihalomethane) 59ug/L. (2019/20 av. 31ug/L) WHO Guideline level BDCM: 60ug/L (Australian Guideline for BDCM is included in the Trihalomethane (THM) combined total of BDCM, Chloroform, Dibromochloromethane and Bromoform. THM guideline is 250ug/L) “Carcinogenicity : Bromodichloromethane is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals. Cancer Studies in Experimental Animals: Oral exposure to bromodichloromethane caused tumors at several different tissue sites in mice and rats. Administration of bromodichloromethane by stomach tube caused benign and malignant kidney tumors (tubular-cell adenoma and adenocarcinoma) in male mice and in rats of both sexes, benign and malignant liver tumors (hepatocellular adenoma and carcinoma) in female mice, and benign and malignant colon tumors (adenomatous polyps and adenocarcinoma) in rats of both sexes (NTP 1987, ATSDR 1989, IARC 1991, 1999). Since bromodichloromethane was listed in the Sixth Annual Report on Carcinogens, additional studies in rats have been identified. Administration of bromodichloromethane in the drinking water increased the combined incidence of benign and malignant liver tumors (hepatocellular adenoma or carcinoma) in males (George et al. 2002) and caused benign liver tumors (hepatocellular adenoma) in females (Tumasonis et al. 1987). Cancer Studies in Humans The data available from epidemiological studies are inadequate to evaluate the relationship between human cancer and exposure specifically to bromodichloromethane. Several epidemiological studies indicated a possible association between ingestion of chlorinated drinking water (which typically contains bromodichloromethane) and increased risk of cancer in humans, but these studies could not provide information on whether any observed effects were due to bromodichloromethane or to one or more of the hundreds of other disinfection by-products also present in chlorinated water (ATSDR 1989).” (1)